A safety evaluation of belatacept for the treatment of kidney transplant-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A safety evaluation of belatacept for the treatment of kidney transplant

Published:2016-06-29 Issue:8 Volume:15 Page:1125-1132
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Garcia Valter Duro¹,Meinerz Gisele²³,Keitel Elizete²³

Affiliation:

1. Head of Renal and Pancreas Transplant Department, Santa Casa de Misericórdia de Porto Alegre (ISCMPA), Porto Alegre, Brazil

2. Post-Graduation Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFSCPA), Porto Alegre, Brazil

3. Renal and Pancreas Transplant Department, ISCMPA, Porto Alegre, Brazil

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2016.1202236

Reference42 articles.

1. Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era

2. Costimulation Blockade with Belatacept in Renal Transplantation

3. Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

4. Belatacept for kidney transplant recipients

5. Belatacept and Long-Term Outcomes in Kidney Transplantation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular Immunobiology and Molecular Mechanisms in Alloimmunity—Pathways of Immunosuppression;Transplantation;2023-12-13

2. Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high‐risk cytomegalovirus serostatus kidney transplant recipients;Transplant Infectious Disease;2022-11-14

3. Immunosuppression and Solid Organ Transplantation;Atlas of Dermatologic Diseases in Solid Organ Transplant Recipients;2022

4. Drugs That Act on the Immune System: Immunosuppressive and Immunostimulatory Drugs;Side Effects of Drugs Annual;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3